TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ARCUTIS

DermatologyImmunology
Pharma

ARCUTIS is a pharmaceutical company focused on Dermatology, Immunology. Key products include ZORYVE.

2022
Since
1
Drugs
-
Trials
4
Approved (2yr)

Key Drugs

ZORYVE
roflumilast
Immunology
PDE4 2 indications · 2022

Recent Activity

ZORYVE 2025-10-04
Efficacy
ZORYVE 2025-05-22
Efficacy
ZORYVE 2024-07-09
Efficacy
ZORYVE 2024-06-12
Manufacturing (CMC)
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 51%
1 drugs Phase 3: 5 Phase 2: 4 Phase 1: 2
Immunology 49%
1 drugs Phase 3: 4 Phase 2: 5 Phase 1: 3

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Dermatology, Immunology
Eli Lilly big-pharma
Immunology, Dermatology
BAUSCH specialty
Dermatology, Immunology
COSETTE other
Dermatology, Immunology
BAUSCH AND LOMB specialty
Dermatology, Immunology